STM-01 is an allogeneic neonatal cardiac progenitor cell (nCPC) therapy designed to treat various inflammatory cardiovascular diseases such as HFpEF. The Fast Track designation was based on STM-01 ...

Correspondence to Professor Guy Boeckxstaens, Translational Research in Gastrointestinal Disorders (TARGID), Department of Chronic Diseases, Metabolism and Ageing (Chrometa), KU Leuven, Leuven, ...